VYNE Therapeutics (VYNE) Receivables - Other (2020 - 2021)
VYNE Therapeutics (VYNE) has disclosed Receivables - Other for 2 consecutive years, with $5.5 million as the latest value for Q4 2021.
- For the quarter ending Q4 2021, Receivables - Other fell 5.17% year-over-year to $5.5 million, compared with a TTM value of $5.5 million through Dec 2021, down 5.17%, and an annual FY2021 reading of $5.5 million, down 5.17% over the prior year.
- Receivables - Other was $5.5 million for Q4 2021 at VYNE Therapeutics, down from $7.3 million in the prior quarter.
- Across five years, Receivables - Other topped out at $8.1 million in Q1 2021 and bottomed at $4.0 million in Q2 2020.